|
500660 GLAXO Group (A) 11 Aug,15:28
2601.00
0.00 (0.00%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
Invest & Trade in GLAXO on dhan
1 min read
2 hours ago
1 min read
2 hours ago
1 min read
3 hours ago
2 min read
3 hours ago
| Mar ' 26 | Mar ' 25 | Mar ' 24 | Mar ' 23 | Mar ' 22 | |
|---|---|---|---|---|---|
| Sales | 3,790.20 | 3,723.49 | 3,407.25 | 3,216.34 | 3,217.51 |
| Operating profit | 1,300.20 | 1,169.29 | 900.65 | 799.41 | 755.83 |
| Interest | 2.73 | 1.31 | 1.80 | 1.81 | 1.99 |
| Gross profit | 1,440.03 | 1,310.54 | 1,022.33 | 899.12 | 830.06 |
| EPS (Rs) | 59.73 | 54.25 | 34.51 | 35.87 | 99.79 |
1 min read
2 hours ago
1 min read
2 hours ago
Q: What is the current share price of GlaxoSmithKline Pharmaceuticals Ltd.?
A: The current share price of GlaxoSmithKline Pharmaceuticals Ltd. is ₹ 2601.00 (for BSE as on 11 Aug,15:28). The 52-week range is ₹ 2,899.90 - 2,088.00. Prices are updated based on live market data.
Q: What is the market capitalization of GlaxoSmithKline Pharmaceuticals Ltd.?
A: GlaxoSmithKline Pharmaceuticals Ltd. has a market capitalization of ₹ 44,060.95 Cr, making it a company.
Q: What is the PE ratio of GlaxoSmithKline Pharmaceuticals Ltd.?
A: The Price-to-Earnings (PE) ratio of GlaxoSmithKline Pharmaceuticals Ltd. is 43.59, indicating its valuation relative to earnings.
Q: Is GlaxoSmithKline Pharmaceuticals Ltd. a good investment?
A: GlaxoSmithKline Pharmaceuticals Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: Does GlaxoSmithKline Pharmaceuticals Ltd. pay dividends?
A: Yes. GlaxoSmithKline Pharmaceuticals Ltd. pay dividends. The latest dividend yield is 570%.
Q: What are the latest financial results of GlaxoSmithKline Pharmaceuticals Ltd.?
A: GlaxoSmithKline Pharmaceuticals Ltd. has reported its latest annual results with revenue of ₹ 3,790.20 and net profit/loss of ₹ 1,011.82.
